Dendritic Cell Based Therapy for Breast Cancer Patients
NCT00935558
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
no patients enrolled
Conditions
Breast Cancer
Interventions
BIOLOGICAL:
DC vaccine
DRUG:
aromatase inhibitor
Sponsor
Inge Marie Svane